Thomas Zindrick

Mr. Zindrick was elected to the position of Executive Vice Chairman at Aeromics in March 2019 and Executive Chairman in July 2020 and is responsible for strategic business operations at Aerobics. Mr. Zindrick brings over 25 years of executive experience in the life sciences and biotechnology and has also currently served as President & Chief Executive Officer of Genelux Corporation since 2014. Mr. Zindrick retired from Amgen, Inc. in 2009 after a distinguished 16-year career. While at Amgen, he held positions of increasing responsibility, including Vice President, Associate General Counsel, and Chief Compliance Officer. As Vice President, Associate General Counsel, Mr. Zindrick led intellectual property, licensing, and regulatory law teams and served on cross-functional business and product development teams. These teams were responsible for acquisitions totaling over $20 billion and the licensing and development of six therapeutic products and numerous clinical candidates. As Chief Compliance Officer, he reported to the Board of Directors and led the Corporate Compliance Program, which oversaw the compliance activities of numerous company functions including product development, manufacturing, and marketing.